# Copart

Type: Company (CPRT)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/copart
Canonical HTML page: https://getfinancebrief.com/entity/copart

## Timeline

- **2026-02-20**: Candel Public Offering — Candel Therapeutics prices $100M public offering at $5.45 per share.
- **2026-02-20**: Trial Data Release — Grail shares slide as NHS-Galleri trial misses primary endpoint for late-stage cancer reduction.
- **2026-02-20**: GDP Release — U.S. government scheduled to release Q4 GDP growth figures at 8:30 AM ET.
- **2026-02-19**: Grail Earnings — Grail reports Q4 and Full Year 2025 financial results, beating revenue and EPS estimates.

## Recent coverage (1 stories)

### US Futures Rebound as Markets Await Pivotal Q4 GDP Growth Data
2026-02-20 12:42:09 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

US equity futures signaled a positive open on Friday as investors shifted focus toward the release of fourth-quarter GDP figures. Following a lackluster Thursday session, the market is looking for confirmation of economic resilience while monitoring individual movers like Grail and Candel Therapeutics.
Full story: https://getfinancebrief.com/story/us-futures-rebound-gdp-data-grail-candel

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.